e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Epidemiology and control of tuberculosis and LTBI
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers
H. Fjallbrant, L. O. Larsson, M. Ridell (Gothenburg, Stockholm, Sweden)
Source:
Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Session:
Epidemiology and control of tuberculosis and LTBI
Session type:
Oral Presentation
Number:
3143
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Fjallbrant, L. O. Larsson, M. Ridell (Gothenburg, Stockholm, Sweden). Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers. Eur Respir J 2005; 26: Suppl. 49, 3143
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
State of the art in vaccine development against TB
Source: Eur Respir Mon 2012; 58: 59-71
Year: 2012
Do antimicrobial peptides shape the adaptive immune response?
Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease
Year: 2005
Pneumococcal and influenza vaccination
Source: Respipedia Article
Year: 2018
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
Source: Eur Respir J 2001; 18: Suppl. 33, 307s
Year: 2001
Relationship between the whole blood interferon-gamma responses and the risk of active tuberculosis
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
BCG vaccination in childhood is not related to pulmonary immunity against
M. tuberculosis
in adults
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults
Source: Eur Respir J 2014; 44: 1087-1090
Year: 2014
Humoral immune response to influenza vaccination in silicosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 695s
Year: 2006
Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis
Source: Eur Respir J 2007; 29: 143-148
Year: 2007
Mucosal immunity and novel vaccines against tuberculosis
Source: Lung Science Conference 2015
Year: 2015
The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 656s
Year: 2005
TB in children
Source: Eur Respir Mon 2012; 58: 206-218
Year: 2012
MAIT cells contribute to a protective antiviral innate response to influenza infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
The humoral immune response to influenza vaccination in lung transplant patients
Source: Eur Respir J 2001; 18: 971-976
Year: 2001
The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test
Source: Eur Respir J 2006; 28: 16-23
Year: 2006
In vitro
immune response to
Mycobacterium tuberculosis
antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005
Monitoring T-cell immunity towards
M. tuberculosis
: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept